{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T13:24:57Z","timestamp":1771421097779,"version":"3.50.1"},"posted":{"date-parts":[[2026,2,18]]},"group-title":"In Review","reference-count":29,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,12,12]]},"abstract":"<title>Abstract<\/title>\n                <p>Background: People who use drugs (PWUDs) have an increased risk of acquiring and transmitting bloodborne diseases, including HIV, hepatitis B and C virus. To manage HIV among people who use drugs and live with HIV (PUD-LWH), health services provide integrated Medication-Assisted and Antiretroviral Treatment Services (IMAT services). Although the IMAT comprehensive care package includes biological, social, and psychological interventions, PUD-LWH's retention in care is suboptimal. A formative needs assessment collected qualitative information to inform adaptation for PUD-LWH of an evidence-based peer-led group psychosocial intervention that showed good clinical and psychosocial outcomes in people living with HIV.\nMethods: We conducted in-depth interviews with 22 PUD-LWH to understand users' experiences with IMAT services. Healthcare providers (n=6) also participated. Thematic areas explored included perceptions of how the IMAT services process met users' needs, experiences when attending IMAT services, including perceived benefits and challenges, and proposed strategies to overcome reported difficulties. Narrative data were analyzed using thematic analysis.\nResults: PUD-LWH perceived themselves as physically and mentally stable and acknowledged that IMAT had helped them re-integrate with families. Enacted stigma, out-of-pocket healthcare expenses, and limited time with healthcare providers due to an overburdened IMAT service were challenges to maintaining adherence to IMAT clinic visits and ART medication use. Participants proposed strategies to continue building awareness of IMAT services, reduce enacted stigma related to drug use, enhance client psychosocial care, facilitate the provision of skills for improving income generation for PUD-LWH, and increase the number of IMAT healthcare providers.\nConclusions: This formative study reveals individual, family, and community-level facilitators and barriers to accessing and using IMAT services and IMAT services-based structural challenges. IMAT services clients by suggesting strategies to overcome structural challenges.<\/p>","DOI":"10.21203\/rs.3.rs-8346864\/v1","type":"posted-content","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T12:56:46Z","timestamp":1771419406000},"source":"Crossref","is-referenced-by-count":0,"title":["Individual and structural benefits, challenges, and strategies for integrating medication assistance treatment and antiretroviral services for persons living with HIV who use drugs in Dar es Salaam, Tanzania"],"prefix":"10.21203","author":[{"given":"Dorothy","family":"Mushi","sequence":"first","affiliation":[{"name":"Muhimbili University of Health and Allied Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Sakejo","sequence":"additional","affiliation":[{"name":"Muhimbili University of Health and Allied Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magreat","family":"Somba","sequence":"additional","affiliation":[{"name":"Ifakara Health Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Huh","sequence":"additional","affiliation":[{"name":"University of Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepa","family":"Rao","sequence":"additional","affiliation":[{"name":"University of Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Kaaya","sequence":"additional","affiliation":[{"name":"Muhimbili University of Health and Allied Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","volume-title":"World Drug Report 2023","author":"UNODC","year":"2023","unstructured":"UNODC. World Drug Report 2023. United Nations publication; 2023."},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. American Psychiatric Pub; 2013."},{"key":"ref3","volume-title":"Prevention and control of infectious diseases among people who inject drugs: 2023 update","author":"European Centre for Disease Prevention and Control (ECDC) and European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)","year":"2023","unstructured":"European Centre for Disease Prevention and Control (ECDC) and European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Prevention and control of infectious diseases among people who inject drugs: 2023 update. Stockholm: ECDC; 2023."},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-020-00364-5","article-title":"Prevalence and risk factors associated with HIV-1 infection among people who inject drugs in Dar es Salaam, Tanzania: A sign of successful intervention?","volume":"17","author":"Likindikoki SL","year":"2020","unstructured":"Likindikoki SL, Mmbaga EJ, Leyna GH, Moen K, Makyao N, Mizinduko M, et al. Prevalence and risk factors associated with HIV-1 infection among people who inject drugs in Dar es Salaam, Tanzania: A sign of successful intervention? Harm Reduct J. 2020;17(1):1\u201310.","journal-title":"Harm Reduct J"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.drugpo.2012.08.005","article-title":"An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of bloodborne viruses among drug users in Temeke District, Dar-es-Salaam, 2011","volume":"24","author":"Bowring AL","year":"2013","unstructured":"Bowring AL, Luhmann N, Pont S, Debaulieu C, Derozier S, Asouab F, Toufik A, van Gemert C, Dietze P, Stoove M. An urgent need to scale-up injecting drug harm reduction services in Tanzania: prevalence of bloodborne viruses among drug users in Temeke District, Dar-es-Salaam, 2011. Int J Drug Policy. 2013;24(1):78\u201381.","journal-title":"Int J Drug Policy"},{"key":"ref6","volume-title":"Community Development, Gender, Elderly and Children","author":"Tanzania Ministry of Health","unstructured":"Tanzania Ministry of Health. Community Development, Gender, Elderly and Children. National AIDS Control Program (NACP)."},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1521\/aeap.2009.21.5.474","article-title":"HIV seroprevalence in a sample of Tanzanian intravenous drug users","volume":"21","author":"Williams ML","year":"2009","unstructured":"Williams ML, McCurdy SA, Bowen AM, Kilonzo GP, Atkinson JS, Ross MW, Leshabari MT. HIV seroprevalence in a sample of Tanzanian intravenous drug users. AIDS Educ Prev. 2009;21(5):474\u201383.","journal-title":"AIDS Educ Prev"},{"key":"ref8","unstructured":"United Nations Programme on HIV\/AIDS. HIV and people who use drugs. UNAIDS report 2021."},{"key":"ref9","volume-title":"Ministry of Health and Social Welfare","author":"Tanzania","year":"2010","unstructured":"Tanzania. Ministry of Health and Social Welfare. Guideline For medically assisted treatment for opioid dependence; 2010."},{"key":"ref10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.drugpo.2016.03.005","article-title":"Improvements in health-related quality of life among methadone maintenance clients in Dar es Salaam","volume":"30","author":"Ubuguyu O","year":"2016","unstructured":"Ubuguyu O, Tran OC, Bruce RD, Masao F, Nyandindi C, Sabuni N, et al. Improvements in health-related quality of life among methadone maintenance clients in Dar es Salaam. Tanzan Int J Drug Policy. 2016;30:74\u201381.","journal-title":"Tanzan Int J Drug Policy"},{"issue":"1","key":"ref11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.drugpo.2013.09.005","article-title":"Lessons from Tanzania on the integration of HIV and tuberculosis treatments into methadone assisted treatment","volume":"25","author":"Bruce RD","year":"2014","unstructured":"Bruce RD, Lambdin B, Chang O, Masao F, Mbwambo J, Mteza I, Nyandindi C, Zamudio-Haas S, Buma D, Dunbar MS, Kilonzo G. Lessons from Tanzania on the integration of HIV and tuberculosis treatments into methadone assisted treatment. Int J Drug Policy. 2014;25(1):22\u20135. 10.1016\/j.drugpo.2013.09.005.","journal-title":"Int J Drug Policy"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3390\/ijerph16050728","article-title":"Evaluating the Integrated Methadone and Antiretroviral Therapy Strategy in Tanzania Using the RE-AIM Framework","volume":"16","author":"Hassan S","year":"2019","unstructured":"Hassan S, Cooke A, Saleem H, Mushi D, Mbwambo J, Lambdin BH. Evaluating the Integrated Methadone and Antiretroviral Therapy Strategy in Tanzania Using the RE-AIM Framework. Int J Environ Res Public Health. 2019;16:728.","journal-title":"Int J Environ Res Public Health"},{"issue":"9738","key":"ref13","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0140-6736(10)60829-X","article-title":"Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs","volume":"376","author":"Altice FL","year":"2010","unstructured":"Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Friedland GH. Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010;376(9738):367\u201387.","journal-title":"Lancet"},{"issue":"6","key":"ref14","first-page":"e382","article-title":"Twelve-month Treatment Retention and Associated Factors: A Comparison of 2 Medically Assisted Therapy Clinics in Dar es Salaam, Tanzania","volume":"01","author":"Mlaki DA","unstructured":"Mlaki DA, Mbwambo JK, McCurdy S, Masao FA, Kaduri PA. Twelve-month Treatment Retention and Associated Factors: A Comparison of 2 Medically Assisted Therapy Clinics in Dar es Salaam, Tanzania. J Addict Med 2022 Nov-Dec 01;16(6):e382\u20139.","journal-title":"J Addict Med 2022 Nov-Dec"},{"key":"ref15","first-page":"8","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo L","year":"2017","unstructured":"Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:8.","journal-title":"BMJ"},{"issue":"3","key":"ref16","doi-asserted-by":"publisher","first-page":"e000946","DOI":"10.1136\/bmjgh-2018-000946","article-title":"Agents of change among people living with HIV and their social networks: stepped-wedge randomised controlled trial of the NAMWEZA intervention in Dar es Salaam, Tanzania","volume":"4","author":"Smith Fawzi MC","year":"2019","unstructured":"Smith Fawzi MC, Siril H, Liu Y, McAdam K, Ainebyona D, McAdam E, Somba M, Oljemark K, Mleli N, Lienert J, Andrew I, Haberlen S, Simwinga A, Todd J, Makongwa S, Li N, Kaaya S. Agents of change among people living with HIV and their social networks: stepped-wedge randomised controlled trial of the NAMWEZA intervention in Dar es Salaam, Tanzania. BMJ Glob Health. 2019;4(3):e000946. 10.1136\/bmjgh-2018-000946.","journal-title":"BMJ Glob Health"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12981-017-0145-z","article-title":"CLINICAL outcomes and Loss to Follow-up among People Living with HIV Participating in the NAMWEZA intervention in Dar es Salaam, Tanzania: a prospective cohort study","volume":"14","author":"Siril HN","year":"2017","unstructured":"Siril HN, Kaaya SF, Smith Fawzi MK, et al. CLINICAL outcomes and Loss to Follow-up among People Living with HIV Participating in the NAMWEZA intervention in Dar es Salaam, Tanzania: a prospective cohort study. AIDS Res Ther. 2017;14:18.","journal-title":"AIDS Res Ther"},{"key":"ref18","first-page":"1","article-title":"Barriers and Facilitators to Effective Implementation of the NAMWEZA Intervention in Dar es Salaam, Tanzania","author":"Somba M","year":"2021","unstructured":"Somba M, Kaaya S, Siril H, Oljemark K, Ainebyona D, McAdam E, Fawzi MCS. Barriers and Facilitators to Effective Implementation of the NAMWEZA Intervention in Dar es Salaam, Tanzania. Prev Sci. 2021, 1\u201310.","journal-title":"Prev Sci"},{"issue":"9","key":"ref19","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1080\/09540121.2020.1826396","article-title":"HIV-positive persons who inject drugs experience poor health outcomes and unmet needs for care services","volume":"33","author":"Dasgupta S","year":"2021","unstructured":"Dasgupta S, Tie Y, Lemons-Lyn A, Broz D, Buchacz K, Shouse RL. HIV-positive persons who inject drugs experience poor health outcomes and unmet needs for care services. AIDS Care. 2021;33(9):1146\u201354.","journal-title":"AIDS Care"},{"issue":"2","key":"ref20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun V","year":"2006","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Res Psychol. 2006;3(2):77\u2013101.","journal-title":"Qualitative Res Psychol"},{"key":"ref21","author":"Tong A","year":"2007","unstructured":"Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care. 2007. Volume 19, Number 6: pp. 349\u2013357."},{"issue":"2","key":"ref22","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1111\/bcp.12031","article-title":"Long-term outcomes of pharmacological treatments for opioid dependence: does methadone still lead the pack?","volume":"77","author":"Garcia-Portilla MP","year":"2014","unstructured":"Garcia-Portilla MP, Bobes-Bascaran MT, Bascaran MT, Saiz PA, Bobes J. Long-term outcomes of pharmacological treatments for opioid dependence: does methadone still lead the pack? Br J Clin Pharmacol. 2014;77(2):272\u201384. 10.1111\/bcp.12031.","journal-title":"Br J Clin Pharmacol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12916-023-03203-z","article-title":"Benefits and challenges experienced by participants on long-term methadone maintenance treatment in China: a qualitative study","volume":"22","author":"Tang X","year":"2024","unstructured":"Tang X, Xiong W, Chen W, et al. Benefits and challenges experienced by participants on long-term methadone maintenance treatment in China: a qualitative study. BMC Med. 2024;22:18. https:\/\/doi.org\/10.1186\/s12916-023-03203-z.","journal-title":"BMC Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1600230","DOI":"10.1080\/2331205X.2019.1600230","article-title":"Improving communication about HIV prevention among people living with HIV and their at-risk social network members in Dar es Salaam, Tanzania","volume":"6","author":"Siril H","year":"2019","unstructured":"Siril H, Kaale A, Minja A, Kilewo J, Mugusi F, Sunguya B, Todd J, Kaaya S, Smith Fawzi MC. Improving communication about HIV prevention among people living with HIV and their at-risk social network members in Dar es Salaam, Tanzania. Cogent Med. 2019;6:1600230.","journal-title":"Cogent Med"},{"issue":"1","key":"ref25","first-page":"71","article-title":"Bahram Armoon. HIV and drug-related stigma and risk-taking behaviors among people who inject drugs: a systematic review and meta-analysis","volume":"2020","author":"AmirHossein Bayat R","unstructured":"AmirHossein Bayat R, Mohammadi M, MoradiJoo A, Bayani E, Ahounbar P, Higgs M, Hemmat A, Haghgoo. & Bahram Armoon. HIV and drug-related stigma and risk-taking behaviors among people who inject drugs: a systematic review and meta-analysis. J Addict Dis.2020,38:1, 71\u201383.","journal-title":"J Addict Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s11904-022-00619-9","article-title":"Measuring and Addressing Stigma Within HIV Interventions for People Who Use Drugs: a Scoping Review of Recent Research","volume":"19","author":"Lancaster KE","year":"2022","unstructured":"Lancaster KE, Endres-Dighe S, Sucaldito AD, et al. Measuring and Addressing Stigma Within HIV Interventions for People Who Use Drugs: a Scoping Review of Recent Research. Curr HIV\/AIDS Rep. 2022;19:301\u201311.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1080\/09540121.2022.2032575","article-title":"HIV status disclosure, and ART adherence in the context of an integrated opioid use disorder and HIV treatment setting in Dar es Salaam, Tanzania","volume":"35","author":"Saleem HT","year":"2023","unstructured":"Saleem HT, Knight D, Yang C, Kidorf M, Latkin C, Nkya IH, HIV, Stigma. HIV status disclosure, and ART adherence in the context of an integrated opioid use disorder and HIV treatment setting in Dar es Salaam, Tanzania. AIDS Care. 2023;35(1):91\u20134.","journal-title":"AIDS Care"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13722-023-00374-1","article-title":"Economic, social, and clinic influences on opioid treatment program retention in Dar es Salaam, Tanzania: a qualitative study","volume":"18","author":"Knight D","year":"2023","unstructured":"Knight D, Nkya IH, West NS, et al. Economic, social, and clinic influences on opioid treatment program retention in Dar es Salaam, Tanzania: a qualitative study. Addict Sci Clin Pract. 2023;18:19.","journal-title":"Addict Sci Clin Pract"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/hex.13779","article-title":"Exploring the impact of engagement in mental health and substance use research: A scoping review and thematic analysis","volume":"26","author":"Sheikhan NY","year":"2023","unstructured":"Sheikhan NY, Kuluski K, McKee S, Hiebert M, Hawke LD. Exploring the impact of engagement in mental health and substance use research: A scoping review and thematic analysis. Health Expect. 2023;26(5):1806\u201319.","journal-title":"Health Expect"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8346864\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8346864\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T12:56:59Z","timestamp":1771419419000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8346864\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":29,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-8346864\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,2,18]]},"subtype":"preprint"}}